Vevye offers a semiflourinated alkane formulation that targets dry eye inflammation by enhancing the penetration of ...
The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.
The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ...
Recent estimates show that there are over 2 billion users on Instagram, of which over 726.8 million interact with reels on ...
Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...
The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...